OneSource Specialty Pharma Limited (ONESOURCE) Stock Statistics & Valuation Metrics

OneSource Specialty Pharma Limited has a market cap or net worth of ₹136.70B. The enterprise value is ₹187.72B.

OneSource Specialty Pharma Limited has 114,585,140 shares outstanding. The number of shares has decreased by -2.65% in one year.

OneSource Specialty Pharma Limited’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -146.99%.

The current PE Ratio of OneSource Specialty Pharma Limited is 675.7. OneSource Specialty Pharma Limited’s PEG ratio is 0.00.

In the last 12 months, OneSource Specialty Pharma Limited had revenue of 14.45B and earned -2.10M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

OneSource Specialty Pharma Limited pays an annual dividend of ―, resulting in a dividend yield of ―

OneSource Specialty Pharma Limited upcoming earnings date is May 11, 2026, Before Open (Confirmed).

OneSource Specialty Pharma Limited as a current ratio of 83.44, with Debt / Equity ratio of ―

In the past 12 months, OneSource Specialty Pharma Limited has paid -497.85M in taxes.

OneSource Specialty Pharma Limited EV to EBITDA ratio is 52.01, with an EV/FCF ratio of -95.78.

OneSource Specialty Pharma Limited has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 13.18%, and net profit margin of -0.01%.

The average price target for OneSource Specialty Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy